Dynavax Technologies Corporation Net Income Quarterly:

-20.82M for Dec. 31, 2012
View Full Chart

Dynavax Technologies Corporation Net Income Quarterly Chart

    Dynavax Technologies Corporation Historical Net Income Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -20.82M
    Dec. 31, 2012 -20.54M
    Sept. 30, 2012 -17.79M
    June 30, 2012 -15.11M
    March 31, 2012 -16.50M
    Dec. 31, 2011 -4.267M
    Sept. 30, 2011 -15.23M
    June 30, 2011 -10.64M
    March 31, 2011 -18.47M
    Dec. 31, 2010 -15.12M
    Sept. 30, 2010 -4.998M
    June 30, 2010 -28.00M
    March 31, 2010 -9.184M
    Dec. 31, 2009 -30.27M
    Sept. 30, 2009 -9.506M
    June 30, 2009 4.11M
    March 31, 2009 5.101M
    Dec. 31, 2008 3.099M
    Sept. 30, 2008 -5.42M
    June 30, 2008 -6.079M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About Net Income

    Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

    Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
    Learn More

    Get data for

    DVAX Net Income Quarterly Benchmarks

    Companies
    GlaxoSmithKline 1.460B
    Anika Therapeutics 3.068M
    Array BioPharma -21.59M

    DVAX Net Income Quarterly Rankings

    Overall 34th percentile
    5221 of 8002
    Sector 11th percentile
    602 of 684 in Healthcare
    Industry 18th percentile
    203 of 248 in Biotechnology

    DVAX Net Income Quarterly Range, Past 5 Years

    Minimum -30.27M Dec 2009
    Maximum 5.101M Mar 2009
    Average -11.78M